Page last updated: 2024-08-22

gadolinium and cangrelor

gadolinium has been researched along with cangrelor in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abdel-Latif, A; Abo-Aly, M; Chelvarajan, L; El-Helw, M; George, B; Shokri, E; Smyth, SS; Ziada, K1

Trials

1 trial(s) available for gadolinium and cangrelor

ArticleYear
Cangrelor in addition to standard therapy reduces cardiac damage and inflammatory markers in patients with ST-segment elevation myocardial infarction.
    Journal of thrombosis and thrombolysis, 2021, Volume: 52, Issue:3

    Topics: Adenosine Monophosphate; Contrast Media; Gadolinium; Humans; Pancreatic Elastase; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Ticagrelor; Treatment Outcome

2021